SapVax, LLC — Form D/A
SapVax, LLC of CLEVELAND, OH, a company, filed a Form D amendment with the SEC on 2019-01-15. The offering totals $5.0M, of which $3.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-01-15
- Form: D/A
- Accession: 0001694191-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.3M
- Remaining: $1.8M
- Investors: 4
- Date of first sale: 2017-01-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-278682
Issuer
- Name: SapVax, LLC
- CIK: 0001694191
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 20600 CHAGRIN BOULEVARD, CLEVELAND, OH, 44122
- Phone: 216-455-3216
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Will Charles | Director | Cleveland, OH |
| Jeff Edelson | Director | Cleveland, OH |
| Baiju Shah | Director | Cleveland, OH |
| Baiju Shah | Executive Officer | Cleveland, OH |
| Terry Vance | Director | Pompano Beach, FL |
Other filings by this issuer (2)
More